openPR Logo
Press release

BIOWEG and Bayer Forge Collaborative Partnership to Develop New Biodegradable Seed Coatings and Formulation Materials

11-15-2023 09:23 AM CET | Energy & Environment

Press release from: BIOWEG

From left to right Heiko Reick; Srinivas Karuturi (BIOWEG COO); Prateek Mahalwar (BIOWEG CEO); Claudia Letmathe; Axel Trautwein

From left to right Heiko Reick; Srinivas Karuturi (BIOWEG COO); Prateek Mahalwar (BIOWEG CEO); Claudia Letmathe; Axel Trautwein

BIOWEG becomes the first startup to join Bayer at its Monheim am Rhein LifeHub.

Monheim, Germany - November 15th, 2023 - Building on its commitment to innovation and collaboration within the European innovation ecosystem, BIOWEG, a pioneering German biotech and material science startup replacing fossil fuel-based ingredients, announces a partnership with Bayer. This partnership will be focused on the development and testing of sustainable formulation materials for seed coatings and the encapsulation of controlled-release plant protection products that are bio-based and bio-degradable. Bayer and BIOWEG signed a Memorandum of Understanding defining concrete further steps in the journey between the two organizations. This underscores both parties' dedication to advancing sustainable agricultural solutions.

As part of the deal, BIOWEG's material R&D team will relocate onsite to Bayer LifeHub Monheim facilities, fostering a dynamic and synergistic partnership. LifeHub Monheim strives to support and leverage innovative start-ups by hosting them in Bayer facilities to allow for close interaction and collaboration. BIOWEG's collaboration with BAYER has been supported by Chemstars and Circular Valley. Notably, Chemstars has played a pivotal role in facilitating BIOWEG's transition to BAYER LifeHub Monheim.

Dr. Prateek Mahalwar, Chief Executive Officer, of BIOWEG, said: "We are thrilled to embark on this partnership with Bayer. This innovative collaboration not only promises to expedite sustainable solutions to the market but also harnesses the strengths of Bayer's agricultural product know-how, seamlessly fused with the dynamic, agile, and innovative work culture of the startup, BIOWEG, on the same campus."

"We are happy to welcome the first start-up company on the campus of Bayer's global Crop Science Division headquarters in Germany as part of our open innovation strategy and our efforts to further complement our innovation capabilities through close interaction with young and innovative start-up companies," said Axel Trautwein, Head of Regulatory Science at Bayer's Crop Science Division.

"Our collaboration with BIOWEG will contribute to Bayer's regenerative agriculture strategy by developing innovative solutions for bio-degradable formulations which have a better environmental profile than those currently available", added Dr. Bernhard Grimmig, Head of Formulation Technology at Crop Science. "We believe that bio-degradable seed coatings and formulation materials together with innovative active ingredients will play an important role in significantly reducing agriculture's impact on the environment."

An Important Step Toward A More Resilient Agri & Food System

Today, seeds undergo a coating process to achieve uniformity in shape, size, weight, and surface. This coating serves multiple purposes, including facilitating easier planting, enhancing seed quality through the application of active compounds, and providing protection against both biological and environmental stresses.

Seed coatings typically comprise polymers, binders, colorants, minerals, and various additives. These components fall under stringent regulations and are often non-biodegradable. BIOWEG has developed bio-degradable and bio-based alternatives to agricultural coatings and beyond to other agricultural formulation materials. Its sustainable and customizable solutions are solving several challenges, such as tunable release, loading of actives or micronutrients, and increasing the microbial load capacity for optimized crop yields. The development of biodegradable seed and fertilizer coatings not only expands the options for growers to get more value from their production, both economically and environmentally. This radically new approach can also help make agriculture and our food system more resilient.

About BIOWEG:

BIOWEG is a biotech and material science company transforming low-value waste streams into high-value ingredients for agriculture, beauty, and food. As a pioneer in sustainable, highly functional, and customizable ingredients, BIOWEG complies with the European Chemical Agency's restriction on the use of polymers in seed and fertilizer coatings and plant protection products. To date, BIOWEG has secured more than 12 million Euros in European Innovation Council funding in 2021 and has forged strategic partnerships with Ginkgo Bioworks and others, to advance their transformative solutions. Recently, BIOWEG has won several innovation awards including Top 3 Sustainability Startup Innovation Award 2023 by LVMH (Global), KfW Gründen Award 2023 by KfW (Germany) and Best Innovative Ingredient Award at Cosmetics 360 Paris (Global).

For more information, visit www.bioweg.com.

BIOWEG
Professor-Von-Klitzing Strasse 11
49610 Quakenbrueck
Germany

E-mail: contact@bioweg.com
Website: https://bioweg.com/

Presscontact: Aleksandra Mincheva (aleksandra@bioweg.com)

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release BIOWEG and Bayer Forge Collaborative Partnership to Develop New Biodegradable Seed Coatings and Formulation Materials here

News-ID: 3287476 • Views:

More Releases for Bayer

Regorafenib Market Analysis By Top Key Players - Bayer Pharmaceuticals, Beacon P …
The "Regorafenib Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031. The market was valued at USD xx.x billion In 2023. Growing Demand and Growth Potential in the Global Regorafenib Market, 2024-2031 Verified Market Research's most recent report, "Regorafenib Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides an in-depth examination of the
Radiopharmaceuticals Market 2022 Sales Revenue - Bracco Imaging, Bayer, Mallinck …
Global Radiopharmaceuticals Market from 2022 to 2028 launched by MarketsandResearch.biz comprises a comprehensive market analysis that encompasses key aspects of the industry and defines current market dynamics in detail. It assesses growth patterns, magnitudes, and specific business developments under the current market scenario. The best statistical surveying and investigation performed with the advanced tools and techniques in this report. The study report shows a balanced presentation of statistical and theoretical
Point of Care Molecular Diagnostics Market Industry Analysis with Abaxis, Inc., …
The Point of Care Molecular Diagnostics Market is set to exceed USD 2.5 billion by 2024; according to a new research study published by Global Market Insights, Inc. Increasing awareness regarding pre-disease diagnosis along with growing incidence of infectious diseases will drive point of care molecular diagnostics market growth. Growing R&D focused on reducing time required for molecular tests will further propel industry growth. However, long product development time and
Companies Profiled in Point of Care Molecular Diagnostics Market are Abaxis, Inc …
Global Point of Care (PoC) molecular diagnostics market is poised to witness robust growth over the forecast period. Increasing infectious diseases incidence coupled with growing public awareness levels pertaining to pre-disease detection to control its occurrence will drive PoC molecular diagnostics market growth. Quick and precise detection of causative agents is of utmost importance in infectious disease emergency cases as the inaccuracy in disease detection leads to incorrect treatment which
Companies Profiled in Point of Care Molecular Diagnostics Market are Abaxis, Inc …
Global Point of Care (PoC) molecular diagnostics market is poised to witness robust growth over the forecast period. Increasing infectious diseases incidence coupled with growing public awareness levels pertaining to pre-disease detection to control its occurrence will drive PoC molecular diagnostics market growth. Quick and precise detection of causative agents is of utmost importance in infectious disease emergency cases as the inaccuracy in disease detection leads to incorrect treatment which
Drug Delivery Market 2018 | Johnson, Bayer
Report Summary The Global Drug Delivery Market Size is primarily driven by the increasing demand for technological advanced products that are used for drug delivery, and increased number of chronic diseases in the increasing number of geriatric population. Drug delivery is referred as drug administration in the human body through injections or various other devices. Drug delivery devices are used to inject the therapeutic substances in the body with the help of